PATENT CLAIM ANALYSIS

Application Number: 16201011
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["606", "152000"]

Abstract:
The present disclosure is directed to the use of fusogenic compounds such as polyethylene glycol (PEG) in combination with antioxidants, calcium-containing and calcium-free solutions for treating damaged nerves, such as for reconnecting severed nerves.

Claim (Index 35):
The method of  claim 23 , wherein the optional antioxidant is methylene blue.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 98.0
- Lexical Diversity: 1.14706
- Patent Class: 606.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15597891', '14001431', '10812776', '10218864', '10218316']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7462556385568527
- 35 USC 102 Novelty (BERT): 0.5588264093722405
- Combined Prediction Score: 0.7275127156383915
- Mean Citation Score: 276.638074
- Max Citation Score: 511.98962
- Similarity Product: 351.86627940228936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test